4.4 Article

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
Volume 70, Issue 45, Pages 1579-1583

Publisher

Centers for Disease Control MMWR Office
DOI: 10.15585/mmwr.mm7045e1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available